Carlyle Group, a major global investment firm, has announced a significant move into the healthcare administration space. The firm has acquired majority stakes in two revenue cycle management (RCM) companies, Knack RCM and EqualizeRCM, with the stated goal of building an "AI-native, global, multi-specialty healthcare RCM platform." This consolidated entity aims to enhance scale and diversify its service offerings, which currently cater to a wide array of providers.
The combined platform will reportedly leverage Knack's global delivery capabilities, spanning the US, India, and the Philippines, alongside its orchestration software, Workmate. EqualizeRCM brings its own complementary RCM services. Together, they are positioned to serve segments including physician groups, durable medical equipment (DME) providers, rural hospitals, urgent care centers, and various specialty practices like anesthesia and eyecare.
Carlyle’s strategy signals a confidence in the growing importance of AI-driven infrastructure within the healthcare sector. The investment firm highlighted its existing experience in healthcare technology, citing prior investments in platforms like Indegene, Visionary RCM, and CorroHealth. This move aligns with Carlyle's broader investment philosophy, described as an "India for the World thesis," and builds on its history of executing similar consolidation strategies in other industries, such as auto components and pharmaceuticals.
Read More: Greg Brockman's OpenAI Stake Valued at $30 Billion
Terms of the transaction were not publicly disclosed. Both Rajiv Sharma, founder of Knack RCM, and Nagi Rao, founder of EqualizeRCM, are expected to remain invested in the new platform through a partial reinvestment of their proceeds.
This expansion by Carlyle into RCM operations occurs amidst broader industry trends focusing on efficiency and value-based care models. The consolidation aims to create a more robust and adaptable RCM solution, intended to meet the evolving demands of the U.S. healthcare landscape.
